Global Negative Pressure Wound Therapy Market Size, Share, and COVID-19 Impact Analysis, By Product (Conventional NPWT Devices, Disposable NPWT Devices, and NPWT Accessories), By Wound (Burns and Surgical & Open Wounds, Pressure Ulcers, Diabetic Foot Ulcers, Venous Leg Ulcers, and Traumatic Wounds), By End-User (Hospitals, Home Care Settings, and Others), By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2022 – 2032Industry: Healthcare
Global Negative Pressure Wound Therapy Market Insights Forecasts to 2032
- The Global Negative Pressure Wound Therapy Market Size was valued at USD 2.79 billion in 2022.
- The market is growing at a CAGR of 6.5% from 2023 to 2032
- The global negative pressure wound therapy market is expected to reach USD 5.24 billion by 2032
- Asia-Pacific is expected to grow the fastest during the forecast period
Get more details on this report -
The Global Negative Pressure Wound Therapy Market Size is expected to reach USD 5.24 billion by 2032, at a CAGR of 6.5% during the forecast period 2023 to 2032.
Negative pressure wound therapy (NPWT), also known as vacuum-assisted wound closure or vacuum therapy, is a medical technique used to treat and manage chronic or complex wounds. It involves the application of controlled negative pressure or vacuum to a wound using specialized devices, which helps in promoting wound healing, reducing wound complications, and accelerating wound closure. NPWT typically involves the use of a device that consists of a wound dressing, a drainage tubing connected to a vacuum source, and a collection canister to collect the wound exudate. The dressing is applied to the wound bed and covered with an airtight seal to create a vacuum environment. The vacuum source generates controlled negative pressure, which helps in removing excess fluid, debris, and bacteria from the wound, promoting blood flow, and stimulating the formation of healthy granulation tissue.
This research report categorizes the market for negative pressure wound therapy market based on various segments and regions and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the negative pressure wound therapy market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segments of the negative pressure wound therapy market.
Global Negative Pressure Wound Therapy Market Report Coverage
|Market Size in 2022:||USD 2.79 Billion|
|Forecast Period:||2022 - 2030|
|Forecast Period 2022 - 2030 CAGR:||6.5%|
|2030 Value Projection:||USD 5.24 Billion|
|Historical Data for:||2018 - 2021|
|No. of Pages:||200|
|Tables, Charts & Figures:||123|
|Segments covered:||By Product, By Wound, By End-User, By Region|
|Companies Covered:||Acelity L.P. Inc., Smith & Nephew, ConvaTec Group PLC, Cardinal Health, Paul Hartmann AG, Medela LLC, Genadyne Biotechnologies, Inc., Triage Meditech Pvt. Ltd., Talley Group, Alleva Medical Ltd., Lohmann & Rauscher GmbH & Co. KG, Devon Medical Products, Mölnlycke Health Care AB|
Get more details on this report -
The negative pressure wound therapy (NPWT) market is driven by several key factors. Firstly, the rising prevalence of chronic wounds, such as diabetic foot ulcers and pressure ulcers, due to factors such as an aging population and increasing incidence of chronic diseases like diabetes and obesity, is driving the demand for advanced wound care solutions like NPWT. Secondly, technological advancements in NPWT devices, including improved design, portability, and connectivity, are enhancing the efficacy and patient compliance of NPWT, driving their adoption in various healthcare settings. Thirdly, the growing awareness among healthcare professionals, patients, and caregivers about the benefits of NPWT in promoting wound healing and reducing complications has led to increased adoption.
The negative pressure wound therapy (NPWT) market faces certain restraints, including the high cost of NPWT devices and consumables, reimbursement challenges, lack of skilled healthcare professionals and training, and regulatory and compliance hurdles. The cost of NPWT devices and consumables may limit accessibility for some patients and healthcare facilities. Reimbursement policies for NPWT can vary, creating challenges for coverage and reimbursement. The lack of skilled healthcare professionals and proper training can hinder adoption. Stringent regulations for product approval and safety standards can pose barriers to market entry and growth. Addressing these restraints will be important for the widespread adoption and growth of the NPWT market.
- In 2022, the conventional NPWT segment accounted for around 53.5% market share
On the basis of product type, the global negative pressure wound therapy market is segmented into conventional NPWT devices, disposable NPWT devices, and NPWT accessories. The conventional NPWT segment is dominating the market with the largest market share in 2022, due to advancements such as enhanced control of severe wound exudates through portable traditional NPWT devices and reduced overall treatment costs, the negative pressure wound therapy (NPWT) market may face impacts on its adoption and utilization in certain markets.
- In 2022, the pressure ulcer segment held around 32.4% market share
Based on the wound type, the global negative pressure wound therapy market is segmented into burns and surgical & open wounds, pressure ulcers, diabetic foot ulcers, venous leg ulcers, and traumatic wounds. Out of this, the pressure ulcer is dominating the market with the largest market share in 2022, due to prolonged hospital stays of patients with pressure ulcers, resulting in increased hospital costs, and the growing utilization of negative pressure wound therapy (NPWT) for the treatment of pressure wounds like bedsores are driving factors behind the growth of NPWT in the market.
- In 2022, the home care settings segment dominated the market with more than 27.3% revenue share
Based on the end-user, the global negative pressure wound therapy market is segmented into hospitals, home care settings, and others. Out of this, home care settings segment dominated the market with the largest market share in 2022. This can be attributed to the rise in the prevalence of age-related diseases, increased demand for disposables and single-use consumables, and the expanding healthcare expenditures.
Regional Segment Analysis of the Negative Pressure Wound Therapy Market
- North America (U.S., Canada, Mexico)
- Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
- Asia-Pacific (China, Japan, India, Rest of APAC)
- South America (Brazil and the Rest of South America)
- The Middle East and Africa (UAE, South Africa, Rest of MEA)
North America dominated the market with the largest share of around 38.7% in 2022.
Get more details on this report -
North America holds a dominant position in the negative pressure wound therapy (NPWT) market, accounting for a significant share of the market. This can be attributed to factors such as the presence of a well-established healthcare infrastructure, increasing prevalence of chronic wounds, favorable reimbursement policies, and robust adoption of advanced healthcare technologies.
In November 2022, Medela LLC has recently announced a new collaboration with MedPro, aimed at expanding access to Medela's comprehensive range of wound treatment systems. Through this collaboration, Medela's reach will be extended to cover nationwide coverage with the support of 60 professional account managers who will serve acute, post-acute, and government channels. This collaboration will complement Medela's dedicated team, reaffirming their commitment to wound care and expanding their presence in the market.
The report offers the appropriate analysis of the key organizations/companies involved within the global negative pressure wound therapy market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
List of Companies:
- Acelity L.P. Inc.
- Smith & Nephew
- ConvaTec Group PLC
- Cardinal Health
- Paul Hartmann AG
- Medela LLC
- Genadyne Biotechnologies, Inc.
- Triage Meditech Pvt. Ltd.
- Talley Group
- Alleva Medical Ltd.
- Lohmann & Rauscher GmbH & Co. KG
- Devon Medical Products
- Mölnlycke Health Care AB
Key Target Audience
- Market Players
- Government Authorities
- Consulting And Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
This study forecasts revenue at global, regional, and country levels from 2019 to 2032. Spherical Insights has segmented the global negative pressure wound therapy market based on the below-mentioned segments:
Negative Pressure Wound Therapy Market, By Product Type
- Conventional NPWT Devices
- Disposable NPWT Devices
- NPWT Accessories
Negative Pressure Wound Therapy Market, By Wound Type
- Burns and Surgical & Open Wounds
- Pressure Ulcers
- Diabetic Foot Ulcers
- Venous Leg Ulcers
- Traumatic Wounds
Negative Pressure Wound Therapy Market, By End-User
- Home Care Settings
Negative Pressure Wound Therapy Market, Regional Analysis
- North America
- Rest of Europe
- Asia Pacific
- South Korea
- Rest of Asia Pacific
- South America
- Rest of South America
- Middle East & Africa
- Saudi Arabia
- South Africa
- Rest of Middle East & Africa
Need help to buy this report?